Varallo, Fabiana Rossi 
; Forgerini, Marcela ; Herdeiro, Maria Teresa Ferreira ; Mastroianni, Patricia de Carvalho
Source: Clinical Therapeutics. Unidade: FCFRP
Subjects: SEGURANÇA DO PACIENTE, FÁRMACOS, FARMACOVIGILÂNCIA, MEDICAMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VARALLO, Fabiana Rossi et al. Harmonization of pharmacovigilance regulation in Brazil: opportunities to improve risk communication. Clinical Therapeutics, v. 41, n. 3, p. 598-603, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.clinthera.2019.01.013. Acesso em: 29 set. 2024.APA
Varallo, F. R., Forgerini, M., Herdeiro, M. T. F., & Mastroianni, P. de C. (2019). Harmonization of pharmacovigilance regulation in Brazil: opportunities to improve risk communication. Clinical Therapeutics, 41( 3), 598-603. doi:10.1016/j.clinthera.2019.01.013NLM
Varallo FR, Forgerini M, Herdeiro MTF, Mastroianni P de C. Harmonization of pharmacovigilance regulation in Brazil: opportunities to improve risk communication [Internet]. Clinical Therapeutics. 2019 ; 41( 3): 598-603.[citado 2024 set. 29 ] Available from: https://doi.org/10.1016/j.clinthera.2019.01.013Vancouver
Varallo FR, Forgerini M, Herdeiro MTF, Mastroianni P de C. Harmonization of pharmacovigilance regulation in Brazil: opportunities to improve risk communication [Internet]. Clinical Therapeutics. 2019 ; 41( 3): 598-603.[citado 2024 set. 29 ] Available from: https://doi.org/10.1016/j.clinthera.2019.01.013
